Eli Lilly and Company Archives - GEN - Genetic Engineering and Biotechnology News

Home 2024

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Drug Discovery

FDA Approves Lilly’s Amyloid-Targeting Kisunla for Early Alzheimer’s

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus

Bioprocessing

Novo Nordisk Plans $4.1B Fill-Finish Plant at Clayton, NC, Campus

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Artificial Intelligence

Insilico Moves HQ to Cambridge, MA, Completes IPF Trial Enrollment

Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing

Drug Discovery

Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing

StockWatch: Amgen Throws Its Weight Behind Obesity Drug

Drug Discovery

StockWatch: Amgen Throws Its Weight Behind Obesity Drug

Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders

Drug Discovery

Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders

Seaport Therapeutics Launches with $100M Series A

Drug Discovery

Seaport Therapeutics Launches with $100M Series A

89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field

Drug Discovery

89bio’s MASH Drug Begins Phase III, Aiming to Stand Out in Growing Field

StockWatch: Challengers Take Aim at Lilly, Novo Nordisk

Drug Discovery

StockWatch: Challengers Take Aim at Lilly, Novo Nordisk

12 3...8 Page 1 of 8